[2] Reichlin T,Hochholzer W,Stelzig C,et al.Incremental value of copeptin for rapid rule out of acute myocardial infarction[J].J Am Coll Cardiol,2009,54(1):60-68.
[2] Chai SB,Hui YM,Li XM,et al.Plasma levels of copeptin in patients with coronary heart disease[J].Heart Vessels,2009,24(2):79-83.
[3] Stoiser B,Mortl D,Husemann M,et al.Copeptin,a fragment of the vasopressin precursor,as a novel predictor of outcome in heart failure[J].Eur J Clin Invest,2006,36(11):771-778.
[4] Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51(3):606-607.
[5] Barat C,Simpson L,Breslow E.Properties of human vasopressin precursor constructs:inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus[J].Biochemistry,2004,43(25):8191-8203.
[6] Kahn M,Morgenthaler N,Wier H,et al.Copeptin,a stable peptide derived from the vasopressin precursor,correlates with the individual stress level[J].Neuro Endoerinol Lett,2008,29(3):341-346.
[7] Tolg R,Witt M,Schwarz B,et al.Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention:the PASSAT Study[J].Clin Res Cardiol,2006,95(1):31-41.
[8] Khan S,Dhillon OS,OBrien RJ,et al.C-terminal provasopressin(copeptin) as a novel and prognostic marker in acute myocardial infarction:Leicester Acute Myocardial Infarction Peptide(LAMP) study[J].Circulation,2007,115(16):2103-2110.
[9] Voors AA,von Haehling S,Anker SD,et al.C-terminal provasopressin(copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction:results from the OPTIMAAL study[J].Eur Heart J,2009,30(10):1187-1194.